Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex & ORCID
How has David M. Kendall's publication output changed over time?
ScholarIQpublication output · 1990–2016
Output grew100% over the shown period — from 1 works in 1990 to 2 in 2016.
1
1
2
1
1
1
1
1
2
199020022005200620072008200920102016
What are the most-cited papers on David M. Kendall?
ScholarIQmost cited works
Effects of Exenatide (Exendin-4) on Glycemic Control Over 30 Weeks in Patients With Type 2 Diabetes Treated With Metformin and a Sulfonylurea
David M. Kendall, Matthew C. Riddle, Julio Rosenstock, Dongliang Zhuang, Dennis Dong Hwan Kim, Mark Fineman, Alain Baron
Diabetes Care. 20051,180 CitationsOPEN ACCESS
Exenatide once weekly versus twice daily for the treatment of type 2 diabetes: a randomised, open-label, non-inferiority study
Daniel J. Drucker, John B. Buse, Kristin Taylor, David M. Kendall, Michael Trautmann, Dongliang Zhuang, Lisa A. Porter
The Lancet. 20081,070 Citations
A Comparison of Lipid and Glycemic Effects of Pioglitazone and Rosiglitazone in Patients With Type 2 Diabetes and Dyslipidemia
Ronald Goldberg, David M. Kendall, Mark A. Deeg, John B. Buse, Anthony J. Zagar, Jane Pinaire, Meng H. Tan, Mehmood Khan, Alfonso T. Perez, Scott J. Jacober, for the GLAI Study Investigators
Diabetes Care. 2005795 CitationsOPEN ACCESS
Interim analysis of the effects of exenatide treatment on A1C, weight and cardiovascular risk factors over 82 weeks in 314 overweight patients with type 2 diabetes
Lawrence Blonde, E. Klein, J. Han, B. Zhang, Susanna Mac, Terri Poon, Kristin Taylor, Michael Trautmann, D. D. Kim, David M. Kendall
Diabetes Obesity and Metabolism. 2006419 CitationsOPEN ACCESS
Recommendations for Management of Diabetes During Ramadan
Monira Alarouj, Samir H. Assaad‐Khalil, John B. Buse, Ibtihal Fahdil, Mohamed A. H. Fahmy, Sherif Hafez, Mohamed Hassanein, Mahmoud Ibrahim, David M. Kendall, Suhail Kishawi, Abdulrazzaq Al-Madani, Abdullah Ben Nakhi, Khaled Tayeb, Abraham Thomas
Diabetes Care. 2010410 CitationsOPEN ACCESS
Related on ScholarIQ
Zealand Pharma (Denmark)
Institution
Effects of Exenatide (Exendin-4) on Glycemic Control Over 30 Weeks in Patients With Type 2 Diabetes Treated With Metformin and a Sulfonylurea
Paper
Exenatide once weekly versus twice daily for the treatment of type 2 diabetes: a randomised, open-label, non-inferiority study
Paper
A Comparison of Lipid and Glycemic Effects of Pioglitazone and Rosiglitazone in Patients With Type 2 Diabetes and Dyslipidemia
Paper
Interim analysis of the effects of exenatide treatment on A1C, weight and cardiovascular risk factors over 82 weeks in 314 overweight patients with type 2 diabetes
Paper
Recommendations for Management of Diabetes During Ramadan
Paper